Hepatocellular carcinoma (HCC) is one of the most prevalent and lethal cancers,
representing a serious worldwide health concern. The recurrence incidence of …

Hepatocellular carcinoma (HCC) is one of the common and fatal malignancies, which is a
significant global health problem. The clinical applicability of traditional surgery and other …

Multikinase inhibitors (MKIs) have been the only first-line treatment for advanced
hepatocellular carcinoma (HCC) for more than a decade, until the approval of immune …

Simple Summary Hepatocellular carcinoma (HCC) is the most frequent primitive cancer of
the liver, accounting for 90% of all recorded cases. HCC is the third most common cause of …

Hepatocellular carcinoma (HCC) is one of the most common and lethal malignant tumors
worldwide. HCC is a complex process that is associated with several etiological factors …

Hepatocellular carcinoma (HCC) represents the most frequent type of primary liver tumor.
Most HCC patients present with advanced disease at diagnosis and the recurrence rate after …

Hepatocellular carcinoma (HCC) is a frequent and increasing cause of cancerrelated deaths
worldwide. Reversing this trend is complicated by the varied aetiological factors leading to …

The global burden of hepatocellular carcinoma (HCC) is increasing and might soon surpass
an annual incidence of 1 million cases. Genomic studies have established the landscape of …

Although the diagnosis of and treatments for hepatocellular carcinoma (HCC) have
advanced remarkably in recent years, HCC is still one of the most common malignancies …

Hepatocellular carcinoma (HCC) is one of the most common solid malignancies worldwide.
A large proportion of patients with HCC are diagnosed at advanced stages and are only …